Foxp3在Treg细胞的表达与结直肠癌预后的研究进展

doi:10.11904/j.issn.1002-3070.2015.03.017

Abstract

Abstract:

In addition to the traditional treatment mode of colorectal cancer(Colorectal cancer,CRC),anti tumor immune treatment gradually becomes the focus.In addition to some clinical pathological factors which affect the prognosis of colorectal carcinoma,the host′s immune response becomes a hotspot.Treg cells involves in immune reaction through immunomodulatory mechanism.Foxp3 as a regulator of Treg plays an important role though suppress proliferation and differentiation of immune cell.The relationship between the expression of Foxp3 in Treg and prognosis in patients with colorectal cancer is closely.The review is to clarify the basic characters of Foxp3 and Treg,the mechanism of Foxp3+Treg cell,the significance between the expression of Foxp3 in Treg and the prognosis of colorectal cancer.

Key words: Foxp3, Treg cells, Colorectal cancer, Prognosis

CLC Number:

R735.3
735.4

GAI Yunzhu,SUN Xiuwei. The relationship between expression of Foxp3 in Treg cells with the prognosis of patients with colorectal cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(3): 267-270.

References

1 Littman DR,Rudensky A.Th17 and regulatory T Cells in mediating and restraining inflammation[J].Cell,2010,140(6):845-858.
2 Roxburgh CS,McMillan DC.The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer[J].Cancer Treat Rev,2012,38(5):451-466.
3 Deschoolmeester V,Baay M,Van Marck E,et al.tumor infiltrating lymphocytes:an intriguing player in the survival of colorectal cancer patients[J].BMC Immunol,2010,11:19.
4 Marzano AV,Vezzoli P,Fanoni D,et al.Primary cutaneous T-cell lymphoma expressing FoxP3:a case report supporting the existence of malignancies of regulatory T cells[J].J Am Acad Dermatol,2009,61(2):348-355.
5 李艳杰,徐开林,潘秀英.CD4⁺T 细胞的研究进展[J].国际输血及血液学杂志,2010,33(1):80-83.
6 张勤英,朱凡,王毓明.结直肠癌患者外周血CD4~+ CD25~(high)调节性T细胞的作用[J].肿瘤基础与临床,2012,25(1):14-17.
7 Fontenot JD,Rasmussen JP,Williams LM,et al.Regulatory T cell lineag specification by the forkhead transcription factor foxp3[J].Immunity,2005,22(3):329-341.
8 Ye J,Ma C,Wang F,et al.Specific recruitment of γδ regulatory T cells in human breast cancer[J].Cancer Res,2013,73(20):6137-6148.
9 Huang Y,Liao H,Zhang Y,et al.Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers:a meta analysis[J].PLoS One,2014,9(5):e94376.
10 叶婧,吴霞,狄文,等.Foxp3在卵巢上皮性癌组织中的表达及其与预后相关性的研究[J].现代妇产科进展,2012,21(10):756-759.
11 Ladoire S,Arnould L,Mignot G,et al.Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy[J].Breast Cancer Res Treat,2011,125(1):65-72.
12 Mahmoud SM,Paish EC,Powe DG,et al.An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer[J].Breast Cancer Res Treat,2011,127(1):99-108.
13 Hinz S,Pagerols-Raluy L,Oberg HH,et al.Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer[J].Cancer Res,2007,67(17):8344-8350.
14 Tao H,Mimura Y,Aoe K,et al.Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells[J].Lung Cancer,2012,75(1):95-101.
15 盖晓东,赵丽微,历春.CD4⁺CD25⁺FOXP3⁺调节性T细胞及其亚型在结直肠癌组织中分布和临床意义的研究[J].中国免疫学杂志,2010,1(5):75-78.
16 Salama P,Phillips M,Grieu F,et al.Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer[J].J Clinical Oncology,2009,27(2):186-192.
17 Liu Z,Huang Q,Liu G,et al.Presence of FOXP3(+)Treg cells is correlated with colorectal cancer progression[J].Int J Clin Exp Med,2014,7(7):1781-1785.
18 Betts G,Jones E,Junaid S,et al.Suppression of tumour-specific CD4⁺T cells by regulatory T cells is associated with progression of human colorectal cancer[J].Gut,2012,61(8):1163-1171.
19 Katz SC,Bamboat ZM,Maker AV,et al.Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases[J].Ann Surg Oncol,2013,20(3):946-955.
20 Loddenkemper C,Schernus M,Noutsias M,et al.In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer[J].J Transl Med,2006,4(1):52-59.
21 Kim M,Grimmig T,Grimm M,et al.Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer[J].PLoS One,2013,8(1):e53630.

[1]	WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.
[2]	FENG Yue,XING Linan,WANG Zhao,ZHANG Yunyan. Correlation between NLR and prognosis of concurrent chemoradiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 284-288.
[3]	BAI Xiaobin, HUO Longwei, XIE Wanfu, XU Gaofeng, WANG Maode. Expression of Chk1 in glioblastoma and its association with tumor biological behavior and prognosis survival [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 122-127.
[4]	SHI Xiaokang, DING Youming, WANG Bin, YU Bin, XU Yu. Expression and clinical significance of UBE2T in primary liver cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 128-133.
[5]	ZHAO Su, ZHENG Xiaoyu, ZHU Kaibin, BU Jianlong, XU Shidong. Effect of complete lung cancer resection on the balance of Th17/Treg in the peripheral blood of patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 142-148.
[6]	FANG Lin, LIU Chao, ZHANG Chunhui, ZHANG Yanqiao. Research status and treatment strategies of maintenance therapy for metastatic colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 173-178.
[7]	TONG Guanghai, TIAN Yang, WU Huaxing. Application of lipidomics in colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 179-192.
[8]	LU Jiaoyun, ZHANG Qingyuan. Advances in laboratory markers in the prognosis of diffuse large B-cell lymphoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 183-187.
[9]	LIU Hengchen, ZHANG Xinyu. Toll-like receptor signaling pathway as a potential therapeutic target for colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 188-192.
[10]	ZHAO Fengjuan, WANG Qi, REN Yunhong, WEI Jueling, LI Lequn, ZHAO Xinhua, TANG Juan, YOU Xuemei. Changes of serum CRP and hs-CRP levels in patients with liver cancer and depression and their influence on prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 27-33.
[11]	ZHANG Fengchun, JIANG Ying, LIU Zhaonan, YAN Ningning, CUI Hongquan, XU Yingchun. Prognostic significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in systemic inflammation-related indicators in gastric cancer patients after radical resection [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 34-39.
[12]	MA Jianli, ZHANG Minghui, JI Hongfei, XU Xiangying. Clinical significance of combined detection of PD-L1 protein and CD8⁺TILs in resected lung adenocarcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 40-46.
[13]	YANG Hongbo, SHI Jie, YE Yong, LI Wencheng, DENG Zhaoping. Expression of COL5A2 in bladder cancer tissues and its correlation with clinicopathological features and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 52-56.
[14]	WANG Yalong, LYU Zhangyan, ZHANG Fan, FENG Xiaoshuang, WEI Luopei, LI Xin, WEN Yan, GAO Yushun, XUE Qi, GAO Shugeng, TAN Fengwei. Relationship between human papillomavirus infection and prognosis of lung cancer:A meta-analysis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 520-526.
[15]	TANG Shuli, HE Kuangbang, ZHANG Chunhui, CHENG Jianan, ZHANG Yanqiao. Expression of miR-320a and CYLD in gastric cancer and its relationship with clinicopathological characteristics and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 538-544.

The relationship between expression of Foxp3 in Treg cells with the prognosis of patients with colorectal cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments